Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT00549523Phase 2Completed
A Phase 2 trial of sutherlandia frutescens extract in human immunodeficiency virus infection (HIV), sponsored by University of Missouri. Started Apr 2008; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT00549523.